BRIDGEWATER BANC(BWBBP) - 2025 Q1 - Quarterly Results
2025-04-24 04:50
Exhibit 99.1 Media Contact: Jessica Stejskal | SVP Marketing Jessica.Stejskal@bwbmn.com | 952.893.6860 Investor Contact: Justin Horstman | VP Investor Relations Justin.Horstman@bwbmn.com | 952.542.5169 April 23, 2025 Bridgewater Bancshares, Inc. Announces First Quarter 2025 Financial Results First Quarter 2025 Highlights (1) Represents a non-GAAP financial measure. See "Non-GAAP Financial Measures" for further details. (2) Core deposits are defined as total deposits less brokered deposits and certificates o ...
Bridgewater Bank(BWB) - 2025 Q1 - Quarterly Results
2025-04-24 04:50
Exhibit 99.1 Media Contact: Jessica Stejskal | SVP Marketing Jessica.Stejskal@bwbmn.com | 952.893.6860 Investor Contact: Justin Horstman | VP Investor Relations Justin.Horstman@bwbmn.com | 952.542.5169 First Quarter 2025 Highlights (1) Represents a non-GAAP financial measure. See "Non-GAAP Financial Measures" for further details. (2) Core deposits are defined as total deposits less brokered deposits and certificates of deposit greater than $250,000. Page 1 of 17 ● Net income of $9.6 million, or $0.31 per di ...
enant Logistics (CVLG) - 2025 Q1 - Quarterly Results
2025-04-24 04:50
Exhibit 99.1 COVENANT LOGISTICS GROUP ANNOUNCES FIRST QUARTER 2025 FINANCIAL AND OPERATING RESULTS CHATTANOOGA, TENNESSEE – April 23, 2025 - Covenant Logistics Group, Inc. (NYSE: CVLG) ("Covenant" or the "Company") announced today financial and operating results for the first quarter ended March 31, 2025. The Company's conference call to discuss the quarter will be held at 10:00 A.M. Eastern Time on Thursday, April 24, 2025. Chairman and Chief Executive Officer, David R. Parker, commented: "Our first quarte ...
BIO-key(BKYI) - 2024 Q4 - Annual Report
2025-04-24 04:49
Table of Contents (Exact name of registrant as specified in its charter) | | | UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM ___ TO ___ COMMISSION FILE NUMBER: 1-13463 BIO-KEY INTERNATIONAL, INC. (State or other jurisdic ...
Amerant Bancorp (AMTB) - 2025 Q1 - Quarterly Results
2025-04-24 04:46
CONTACTS: Investors Laura Rossi InvestorRelations@amerantbank.com (305) 460-8728 Media Alexis Dominguez MediaRelations@amerantbank.com (305) 441-8412 AMERANT REPORTS FIRST QUARTER 2025 RESULTS Board of Directors Declares Quarterly Cash Dividend of $0.09 per Common Share CORAL GABLES, FLORIDA, April 23, 2025. Amerant Bancorp Inc. (NYSE: AMTB) (the "Company" or "Amerant") today reported a net income attributable to the Company of $12.0 million in the first quarter of 2025, or $0.28 income per diluted share, c ...
United Rentals(URI) - 2025 Q1 - Quarterly Results
2025-04-24 04:45
Exhibit 99.1 United Rentals, Inc. 100 First Stamford Place, Suite 700 Stamford, CT 06902 Telephone: 203 622 3131 unitedrentals.com United Rentals Announces First Quarter 2025 Results, Reaffirms Full-Year Guidance, and Introduces New $1.5 Billion Share Repurchase Program STAMFORD, Conn. – April 23, 2025 – United Rentals, Inc. (NYSE: URI) today announced financial results for the first quarter of 2025, reaffirmed its 2025 full-year guidance and announced that its Board of Directors has approved a new $1.5 bil ...
Getty Realty (GTY) - 2025 Q1 - Quarterly Results
2025-04-24 04:45
- No Debt Maturities Until June 2028 - Exhibit 99.1 - Reaffirms 2025 Earnings Guidance - NEW YORK, NY, April 23, 2025 — Getty Realty Corp. (NYSE: GTY) ("Getty" or the "Company"), a net lease REIT focused on convenience and automotive retail real estate, announced today its financial and operating results for the quarter ended March 31, 2025. First Quarter 2025 Highlights "We started the year with another quarter of steady performance as we delivered 3.5% AFFO per share growth, maintained strong portfolio me ...
Penumbra(PEN) - 2025 Q1 - Quarterly Report
2025-04-24 04:44
财务数据关键指标变化 - 2025年和2024年第一季度,公司来自美国以外客户的收入分别占比20.8%和24.8%[108] - 2025年和2024年第一季度,公司收入分别为3.241亿美元和2.787亿美元,增长4550万美元[109] - 2025年和2024年第一季度,公司运营收入分别为4040万美元和1210万美元[109] - 2025年第一季度,公司收入成本为1.083亿美元,占收入的33.4%;2024年同期为9752万美元,占比35.0%[118] - 2025年第一季度,公司研发费用为2208万美元,占收入的6.8%;2024年同期为2463万美元,占比8.8%[118] - 2025年第一季度,公司销售、一般和行政费用为1.535亿美元,占收入的47.3%;2024年同期为1.444亿美元,占比51.8%[118] - 2025年第一季度,公司净收入为3922万美元,占收入的12.1%;2024年同期为1100万美元,占比3.9%[118] - 2025年第一季度总营收3.2414亿美元,较2024年的2.78655亿美元增长16.3%,其中美国市场营收2.5686亿美元,占比79.2%,国际市场营收6730万美元,占比20.8%,较2024年减少170万美元,降幅2.5%[123] - 2025年第一季度毛利率为66.6%,较2024年的65.0%提升1.6个百分点,毛利润为1.81139亿美元,较2024年的2.15883亿美元减少3474.4万美元,降幅19.2%[124] - 2025年第一季度研发费用为2210万美元,较2024年的2460万美元减少250万美元,降幅10.4%,研发费用占营收比例从8.8%降至6.8%[125] - 2025年第一季度销售、一般和行政费用为1.535亿美元,较2024年的1.444亿美元增加900万美元,增幅6.3%,占营收比例从51.8%降至47.3%[127] - 2025年第一季度所得税费用为460万美元,占税前收入的10.6%,较2024年的360万美元(占比24.8%)增加100万美元,增幅27.9%[130] - 2025年第一季度经营活动产生的净现金为4900万美元,投资活动使用的净现金为50万美元,融资活动产生的净现金为270万美元[136] 各条业务线数据关键指标变化 - 2025年第一季度,公司血栓切除产品收入为2.265亿美元,较2024年同期增长3884万美元,增幅20.7%[119] - 2025年第一季度,公司栓塞和通路产品收入为9760万美元,较2024年同期增长664万美元,增幅7.3%[119] - 2025年第一季度,美国血栓切除产品销售额增长25.0%,美国栓塞和通路产品销售额增长16.2%[120][121] 公司资金状况 - 截至2025年3月31日,公司营运资金为8.411亿美元,其中现金及现金等价物为3.761亿美元,有价投资为280万美元,约6.0%的现金及现金等价物存于海外实体[132] - 截至2025年3月31日,公司现金及现金等价物为3.761亿美元,主要包括商业票据、货币市场基金等;有价投资为280万美元,主要是美国国债[152] 公司股票回购情况 - 公司董事会于2024年8月5日批准最高2亿美元的股票回购授权,截至2025年3月31日,剩余1亿美元的回购额度[134] 公司重大项目建设 - 2025年第一季度公司签订协议在哥斯达黎加购置房产并建设医疗设备制造工厂和仓库[133][146] 公司合同义务情况 - 截至2025年3月31日,公司的合同义务和承诺与2024年12月31日披露的相比无重大变化[147] 公司财务报表编制相关 - 公司按美国公认会计原则编制财务报表,需进行估计、假设和判断,实际结果可能与估计有重大差异[148] - 公司关键会计政策自2024年12月31日结束年度的10 - K表格年度报告以来无重大变化[149] - 关于最近发布的会计准则及其对合并财务报表的影响,可参考10 - Q表格季度报告第一部分第1项中合并财务报表附注“2. 重要会计政策摘要”[150] 公司市场风险情况 - 公司面临市场风险,包括利率和外汇汇率不利变化带来的潜在损失,但现金、现金等价物和有价投资无重大市场风险[151] - 假设利率变动100个基点,对公司现金及现金等价物或有价投资价值无重大影响[152] - 公司在非美国国家运营,面临外汇风险,以当地货币(主要是欧元)开票,不认为外汇汇率立即不利变动10%会对净收入产生重大影响,目前未对冲外汇风险[153] 公司毛利率影响因素 - 2025年第一季度公司毛利率主要受各地区有利产品组合和生产率提高影响,价格变化对合并财务报表各期经营成果无重大影响[154]
Amedisys(AMED) - 2025 Q1 - Quarterly Results
2025-04-24 04:44
Exhibit 10.1 EXECUTION VERSION FOURTH AMENDMENT TO AMENDED AND RESTATED CREDIT AGREEMENT THIS FOURTH AMENDMENT TO AMENDED AND RESTATED CREDIT AGREEMENT (this "Agreement"), dated as of April 17, 2025 (the "Fourth Amendment Effective Date"), is entered into among AMEDISYS, INC., a Delaware corporation (the "Company"), AMEDISYS HOLDING, L.L.C., a Louisiana limited liability company ("Amedisys Holding"; Amedisys Holding, together with the Company, each a "Borrower" and collectively, the "Borrowers"), the Guaran ...
The St. Joe pany(JOE) - 2025 Q1 - Quarterly Report
2025-04-24 04:43
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number: 1-10466 The St. Joe Company (Exact name of registrant as specified in its charter) | Florida | 59-0432511 | | - ...